GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Guerbet SA (FRA:4G8) » Definitions » Common Stock

Guerbet (FRA:4G8) Common Stock : €12.6 Mil (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Guerbet Common Stock?

Guerbet's quarterly common stock stayed the same from Jun. 2023 (€12.6 Mil) to Dec. 2023 (€12.6 Mil) and stayed the same from Dec. 2023 (€12.6 Mil) to Jun. 2024 (€12.6 Mil).

Guerbet's annual common stock stayed the same from Dec. 2021 (€12.6 Mil) to Dec. 2022 (€12.6 Mil) and stayed the same from Dec. 2022 (€12.6 Mil) to Dec. 2023 (€12.6 Mil).


Guerbet Common Stock Historical Data

The historical data trend for Guerbet's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guerbet Common Stock Chart

Guerbet Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.60 12.60 12.64 12.64 12.64

Guerbet Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.64 12.64 12.64 12.64 12.64

Guerbet Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Guerbet Business Description

Traded in Other Exchanges
Address
15 rue des Vanesses, Zone Paris Nord II, Villepinte, FRA, 93420
Guerbet SA is a healthcare company that manufactures and markets medical imaging contrast agents destined for diagnostic purposes. Its products include medical imaging contrast products for x-ray imaging, magnetic resonance imaging, ultrasound imaging and for nuclear medicine. The company markets its products under the brand names such as Xenetix, Optiray, Oxilan, Telebrix, Lipiodol, Dotarem, Endorem, Artirem, Lumirem, and Lipiodol.

Guerbet Headlines

No Headlines